“Controlled Release Drug Delivery Market & Pipeline Insight” Report Highlights: Controlled Release Drug Delivery Market Overview Controlled Release Drug Delivery Mechanism Clinical Pipeline by Phase & Target Indications Drug Profiles in Report: 451 Drug Profile in Active Clinical Phase (Research till Registration): 234 Majority of Controlled Release Drug in Phase-II Development: 58 Marketed Controlled Release Drugs: 140 Suspended & Discontinued Drug Profiles

1. Page 1
Controlled Release Drug Delivery Market Offers Unexplored Opportunities
“Controlled Release Drug Delivery Market & Pipeline Insight” Report Highlights:
 Controlled Release Drug Delivery Market Overview
 Controlled Release Drug Delivery Mechanism
 Clinical Pipeline by Phase & Target Indications
 Drug Profiles in Report: 451
 Drug Profile in Active Clinical Phase (Research till Registration): 234
 Majority of Controlled Release Drug in Phase-II Development: 58
 Marketed Controlled Release Drugs: 140
 Suspended & Discontinued Drug Profiles
The popularity and usage of controlled drug release system has increased by many folds in the recent past
owing to various advantages offered by this system which include reduced delivery times, thus improving
patient compliance rate, improved levels of clinical efficacy to reduce the side effects and increase
bioavailability. Additionally, this system has become significant because it has been proved that the molding
technology used in the controlled delivery of drugs also considers the biological, physical chemistry and
mechanics of content.
Additionally, it has been observed that the aspects regarding the pharmacology and clinical efficiency
coupled with the advantages offered by the controlled release of pharmaceutical formulations could
possible lead to significant economic benefits. These benefits could be in the field of intellectual property,
brand differentiation and promotion. Also, with the increasing trend of transferring the technology to other
companies could also possibly yield large profits margins for the companies investing in this area.
The pharma companies, in recent years, have identified many advantages which are offered by the
controlled drug delivery technology, which is a major driver of this market and reflects the growing need for
this technology. It is because of these advantages that both the patients and the physicians are striving to
use more of these systems to transport drugs and deliver them to the exact target tissue so as to improvise
on the treatment methods of diseases.
For Report Sample Contact avinash@kuickresearch.com